Chesnara Plc: Acquisitions show immediate benefits
2 September 2026
DexCom, Inc. (NASDAQ: DXCM), a leading player in the healthcare sector, specializes in the medical devices industry, focusing on continuous glucose monitoring (CGM) systems. With a market capitalization of $31.09..
Mettler-Toledo International, Inc. (NYSE: MTD) is a formidable player in the diagnostics and research sector within the healthcare industry. The company, with a substantial market cap of $24.88 billion, is..
Bio-Techne Corporation (NASDAQ: TECH), a key player in the biotechnology sector, presents a compelling case for investors with a significant potential upside of 21.15%. Headquartered in Minneapolis, Minnesota, the company..
RadNet, Inc. (NASDAQ: RDNT), a key player in the healthcare sector, specifically within the diagnostics and research industry, presents a compelling case for investors seeking growth opportunities in the medical..
Summit Therapeutics Inc. (SMMT) stands as a noteworthy player in the biotechnology industry, commanding attention with its $20.1 billion market capitalization. The company, headquartered in Miami, Florida, is making waves..
Walgreens Boots Alliance, Inc. (NASDAQ: WBA), a stalwart in the pharmaceutical retail industry, is drawing investor attention with its notable 8.59% dividend yield, a significant figure in today’s yield-hungry market...
For investors looking to explore opportunities in the healthcare sector, Alkermes plc (NASDAQ: ALKS) presents a compelling case with a potential upside of 56.31%. This Irish-based biopharmaceutical company has carved..
Halozyme Therapeutics, Inc. (NASDAQ: HALO) has carved a significant niche in the biotechnology sector, leveraging its proprietary enzyme technology to transform the delivery and efficacy of injectable therapeutics. With a..
Fresenius Medical Care AG (FMS), a global leader in providing dialysis and related services, continues to captivate investor interest with a promising potential upside of 25.24%. Operating primarily in the..
The Cigna Group (CI), a stalwart in the healthcare sector, presents a compelling opportunity for investors seeking to capitalize on significant growth potential. With a market capitalization of $70 billion,..
Haleon plc (NYSE: HLN), a notable player in the healthcare sector, stands out in the landscape of drug manufacturers specializing in both specialty and generic products. This UK-based company, with..
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), a leader in RNA-targeted drug discovery, continues to capture investor interest with a robust pipeline and strategic collaborations that position it uniquely within the biotechnology..
Investors looking for growth opportunities within the healthcare sector might want to turn their attention to Tenet Healthcare Corporation (NYSE: THC). With a substantial market capitalization of $13.97 billion, Tenet..
Teleflex Incorporated (NYSE: TFX) is a significant player in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in Wayne, Pennsylvania, this United States-based company has carved..
Avantor, Inc. (NYSE: AVTR), a significant player in the healthcare sector, particularly in the medical instruments and supplies industry, is drawing attention from investors with its compelling potential upside. With..
Biogen Inc. (NASDAQ: BIIB), a renowned player in the healthcare sector, continues to captivate investor attention with its robust portfolio in neurological and neurodegenerative therapies. With a market capitalization of..
Baxter International Inc. (NYSE: BAX), a stalwart in the healthcare sector, is currently navigating a complex landscape characterized by both challenges and opportunities. With a market capitalization of $11.27 billion,..
Blueprint Medicines Corporation (NASDAQ: BPMC), a notable player in the biotechnology sector, has captured investor attention with its robust revenue growth and a market cap of $8.37 billion. As a..
Ascendis Pharma A/S (NASDAQ: ASND), a Denmark-based biopharmaceutical innovator, is making waves in the biotechnology sector with its promising TransCon-based therapies. With a current market capitalization of $10.56 billion, Ascendis..
